silybin has been researched along with Cancer of Pancreas in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boroujerdi, M; Gilzad-Kohan, H; Sani, S | 1 |
| Cao, M; Chen, Z; Jiang, J; Zhang, X | 1 |
| Cai, D; Feng, W; Lou, G; Zhang, B; Zou, X | 1 |
| Chaika, NV; Dasgupta, A; Goode, G; Gunda, V; King, R; Mehla, K; Mishra, A; Nagarajan, S; Rai, I; Shukla, SK; Singh, PK; Souchek, J; Vernucci, E; Yu, F | 1 |
| Chen, J; Chen, Y; Dong, Y; Ge, Y; Li, Q; Shi, W; Zhang, Y | 1 |
| Agarwal, R; Nambiar, D; Prajapati, V; Singh, RP | 1 |
6 other study(ies) available for silybin and Cancer of Pancreas
| Article | Year |
|---|---|
Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells.
Topics: Adenosine Triphosphatases; Antimetabolites, Antineoplastic; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Calcitriol; Calcium Channel Agonists; Carrier Proteins; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Silybin; Silymarin | 2017 |
Silibinin inhibited autophagy and mitochondrial apoptosis in pancreatic carcinoma by activating JNK/SAPK signaling.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitochondria; Pancreatic Neoplasms; Silybin | 2019 |
Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells.
Topics: Apoptosis; Caspases; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin B1; Cyclin-Dependent Kinases; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Inhibitor of Apoptosis Proteins; Pancreatic Neoplasms; Silybin; Silymarin; Survivin | 2015 |
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
Topics: Animals; Antioxidants; Cachexia; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Glycolysis; Humans; Immunoblotting; Interleukin-6; Metabolome; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Silybin; Silymarin; STAT3 Transcription Factor; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2015 |
Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Humans; Pancreatic Neoplasms; Silybin; Silymarin | 2011 |
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Dietary Supplements; Humans; Male; Mice, Nude; Neovascularization, Pathologic; Pancreatic Neoplasms; Silybin; Silymarin; Xenograft Model Antitumor Assays | 2013 |